Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA approved Austedo (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults.

Spending on prescription medicines in the United States will increase 4-7 percent through 2021, reaching $580 billion to $610 billion, according to a report released by QuintilesIMS Holdings.

The U.S. Senate voted overwhelmingly to support sweeping legislation that will reshape the way the Food and Drug Administration approves new medicines.

The House of Reps is expected to pass a $6.3 billion piece of legislation designed to spur medical innovation, speed access to new drugs, expand mental health treatment, and combat opioid abuse.

Med Ad News’ first edition of the Pharma Leaders of Innovation special feature showcases two CEOs focusing outside the big pharma box and an agency tech leader.

Even during a humanitarian crisis, treating mental illnesses is not an optional luxury, experts said before a World Bank/World Health Organization meeting on the issue in Washington.

(Reuters Health) – Even though teens get more exercise at school than anywhere else, it still isn’t enough to meet minimum daily activity levels recommended for good physical and mental health, a U.S. study suggests. Children and teens should get at least 60 minutes of moderate to vigorous activity every day, the World Health Organization […]

At least one in five adult New Yorkers suffer from depression, substance abuse, suicidal thoughts or other psychological disorders every year, according to a report released on Thursday ahead of Mayor Bill de Blaiso’s new mental-health initiative.   New York City’s Department of Health and Mental Hygiene expects to release the plan, known as NYC […]

Specialty medicines for which pharmaceutical companies demand high prices are straining wealthy nations’ health budgets, the OECD said on Wednesday, with drugs accounting for some 20 percent of all health spending. Across the 33 OECD countries, pharmaceutical spending reached $800 billion in 2013, and new drugs and rising demand are likely to continue to push […]

Mental health problems like anxiety and depression may partly explain why people with rheumatoid arthritis have an increased risk of cardiovascular disease, according to a new study. Researchers linked anger, anxiety, depressive symptoms, job stress and low social support to increasing risk of hardening of the arteries, or atherosclerosis, for people with rheumatoid arthritis (RA). […]